Antiphospholipid Syndrome and Cancer

Overview

Journal Clin Rev Allergy Immunol

Specialty Allergy & Immunology

Date 2007 Oct 6

PMID 17916991

Citations 8

Authors

Eyal Reinstein

Yehuda Shoenfeld

Affiliations

Soon will be listed here.

Abstract

Thrombosis is a frequent complication of cancer that is a substantial cause of morbidity and mortality. The association of antiphospholipid antibodies (aPL) and cancer has been under investigation for several years. Recent findings suggest an increased prevalence of certain cancers in aPL-positive patients; thus, an intensive search for an occult malignancy is prompted in these patients. In addition, several studies reported on elevated levels of aPL in various malignancies; it seems, however, that aPL levels do not reflect their pathogenicity; therefore, their pathological significance in these subset of patients is still elusive. Continuing research on the association between the antiphospholipid syndrome/aPL and malignancies is important, given the potential impact on the understanding and treatment of both antiphospholipid syndrome and cancer.

Citing Articles

Cancer History, Antiphospholipid Syndrome, and Lupus Anticoagulant: A Perfect Storm for Thrombosis.

Carpintieri S, Uyar E, Anand C, Buryk Y Cureus. 2025; 16(12):e76481.

PMID: 39866992 PMC: 11769576. DOI: 10.7759/cureus.76481.

Criteria and Non-Criteria Antiphospholipid Antibodies and Cancer in Patients with Involuntary Weight Loss.

Caraiola S, Voicu L, Baicus A, Baicus C J Pers Med. 2023; 13(11).

PMID: 38003864 PMC: 10671946. DOI: 10.3390/jpm13111549.

Diagnostic Work-Up in Patients with Nonbacterial Thrombotic Endocarditis.

Tonutti A, Scarfo I, La Canna G, Selmi C, De Santis M J Clin Med. 2023; 12(18).

PMID: 37762758 PMC: 10532023. DOI: 10.3390/jcm12185819.

Role of circulating mitochondria in venous thrombosis in glioblastoma.

Gonzalez-Delgado R, Munoz N, Carlos-Alcalde W, Cho M, Lee H, Jin J J Thromb Haemost. 2023; 21(8):2202-2212.

PMID: 37178770 PMC: 11603921. DOI: 10.1016/j.jtha.2023.04.036.

Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients.

Kansuttiviwat C, Niprapan P, Tantiworawit A, Norasetthada L, Rattarittamrong E, Rattanathammethee T PLoS One. 2023; 18(1):e0279450.

PMID: 36662720 PMC: 9858372. DOI: 10.1371/journal.pone.0279450.

References

Lim W, Crowther M, Eikelboom J . Management of antiphospholipid antibody syndrome: a systematic review. JAMA. 2006; 295(9):1050-7. DOI: 10.1001/jama.295.9.1050. View

Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A . Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Thromb Haemost. 1993; 70(4):568-72. View

Schved J, Biron C, Quere I, Janbon C . A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study. Haemostasis. 1994; 24(3):175-82. DOI: 10.1159/000217099. View

Endler G, Marsik C, Jilma B, Schickbauer T, Vormittag R, Wagner O . Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary report. Clin Chem. 2006; 52(6):1040-4. DOI: 10.1373/clinchem.2005.063925. View

Miesbach W, Asherson R, Cervera R, Shoenfeld Y, Puerta J, Bucciarelli S . The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmun Rev. 2006; 6(2):94-7. DOI: 10.1016/j.autrev.2006.06.012. View

Kozlowski C, Johnson M, Gorst D, Willey R . Lung cancer, immune thrombocytopenia and the lupus inhibitor. Postgrad Med J. 1987; 63(743):793-5. PMC: 2428534. DOI: 10.1136/pgmj.63.743.793. View

Lossos I, Matzner Y . Anticardiolipin antibodies in acute myeloid leukemia: prevalence and clinical significance. Am J Hematol. 1998; 57(2):139-43. DOI: 10.1002/(sici)1096-8652(199802)57:2<139::aid-ajh8>3.0.co;2-x. View

Yahata N, Ohyashiki K, Iwama H, Katagiri T, Kodama S, Tauchi T . Chronic myelomonocytic leukemia in a patient with antiphospholipid syndrome: first case report. Leuk Res. 1997; 21(9):889-90. DOI: 10.1016/s0145-2126(97)00064-7. View

Asherson R . Antiphospholipid antibodies, malignancies and paraproteinemias. J Autoimmun. 2000; 15(2):117-22. DOI: 10.1006/jaut.2000.0404. View

10.

de Laat B, Derksen R, Urbanus R, de Groot P . IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood. 2004; 105(4):1540-5. DOI: 10.1182/blood-2004-09-3387. View

11.

Yoon K, Wong A, Shakespeare T, Sivalingam P . High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis. Lupus. 2003; 12(2):112-6. DOI: 10.1191/0961203303lu328oa. View

12.

Finazzi G . The Italian Registry of Antiphospholipid Antibodies. Haematologica. 1997; 82(1):101-5. View

13.

Miesbach W, Scharrer I, Asherson R . High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma. Clin Rheumatol. 2006; 26(1):95-7. DOI: 10.1007/s10067-006-0328-9. View

14.

Pusterla S, Previtali S, Marziali S, Cortelazzo S, Rossi A, Barbui T . Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. Hematol J. 2004; 5(4):341-6. DOI: 10.1038/sj.thj.6200377. View

15.

Prandoni P, Falanga A, Piccioli A . Cancer and venous thromboembolism. Lancet Oncol. 2005; 6(6):401-10. DOI: 10.1016/S1470-2045(05)70207-2. View

16.

de Groot P, Derksen R . Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost. 2005; 3(8):1854-60. DOI: 10.1111/j.1538-7836.2005.01359.x. View

17.

Park C, Cho H, Kim S . A study on changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma. J Korean Med Sci. 1991; 6(1):1-6. PMC: 3049674. DOI: 10.3346/jkms.1991.6.1.1. View

18.

Donner M, Bekassy N, Garwicz S, Holmberg L, Wiebe T . Cerebral infarction in a girl who developed anticardiolipin syndrome after acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1992; 9(4):377-9. DOI: 10.3109/08880019209016611. View

19.

Cocca B, Seal S, DAgnillo P, Mueller Y, Katsikis P, Rauch J . Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci U S A. 2001; 98(24):13826-31. PMC: 61126. DOI: 10.1073/pnas.241510698. View

20.

Gomez-Puerta J, Cervera R, Espinosa G, Aguilo S, Bucciarelli S, Ramos-Casals M . Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum. 2006; 35(5):322-32. DOI: 10.1016/j.semarthrit.2005.07.003. View